FibroGen Inc (FGEN) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
409 ILLINOIS STREET SAN FRANCISCO, CA 94158 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 177,599 | 235,586 | 251,340 | 335,716 | 355,949 | 422,008 | |||
| Cash and cash equivalents | 105,734 | 113,688 | 120,914 | 152,585 | 188,550 | 155,700 | |||
| Short-term investments | 71,865 | 121,898 | 130,426 | 183,131 | 167,399 | 266,308 | |||
| Receivables | 37,083 | 12,553 | 31,694 | 25,599 | 29,217 | 16,299 | |||
| Inventory, net of allowances, customer advances and progress billings | 27,335 | 41,565 | 40,696 | 41,179 | 42,456 | 40,436 | |||
| Inventory | 27,335 | 41,565 | 40,696 | 41,179 | 42,456 | 40,436 | |||
| Prepaid expense | 5,780 | 6,644 | 9,730 | ||||||
| Other current assets | 1,870 | 6,711 | 4,353 | ||||||
| Other undisclosed current assets | 28,500 | 28,500 | 40,378 | 8,863 | 2,927 | ||||
| Total current assets: | 278,167 | 331,559 | 364,108 | 411,357 | 430,549 | 492,826 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 435 | ||||||||
| Operating lease, right-of-use asset | 64,751 | 68,093 | 71,248 | 74,404 | 76,674 | 79,893 | |||
| Property, plant and equipment | 12,166 | 13,126 | 14,512 | 16,829 | 18,693 | 20,605 | |||
| Long-term investments and receivables | 5,776 | 5,290 | 4,534 | 6,112 | 5,884 | 5,061 | |||
| Long-term investments | 5,776 | 5,290 | 4,534 | 6,112 | 5,884 | 5,061 | |||
| Restricted cash and investments | 1,658 | 1,658 | 2,072 | 2,072 | 2,072 | 2,072 | |||
| Other noncurrent assets | 3,350 | 3,803 | 3,952 | 4,353 | 4,672 | 5,282 | |||
| Other undisclosed noncurrent assets | 3,913 | ||||||||
| Total noncurrent assets: | 87,701 | 91,970 | 96,318 | 103,770 | 107,995 | 117,261 | |||
| TOTAL ASSETS: | 365,868 | 423,529 | 460,426 | 515,127 | 538,544 | 610,087 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 168,639 | 190,851 | 190,206 | 12,802 | 71,282 | 30,758 | |||
| Accounts payable | 4,353 | 17,960 | 19,220 | 12,802 | 71,282 | 30,758 | |||
| Accrued liabilities | 164,286 | 172,891 | 170,986 | ||||||
| Deferred revenue | 12,863 | 12,740 | 7,325 | 7,490 | 16,495 | 12,739 | |||
| Debt | 40 | ||||||||
| Other undisclosed current liabilities | 15,231 | 14,037 | 11,884 | 173,780 | 166,969 | 230,065 | |||
| Total current liabilities: | 196,733 | 217,668 | 209,415 | 194,072 | 254,746 | 273,562 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 72,213 | 72,038 | 71,666 | 71,408 | 137 | ||||
| Long-term debt, excluding current maturities | 72,213 | 71,934 | 71,666 | 71,408 | |||||
| Finance lease, liability | 104 | 137 | |||||||
| Liabilities, other than long-term debt | 213,415 | 226,950 | 228,496 | 244,767 | 248,655 | 271,755 | |||
| Deferred revenue | 147,118 | 157,555 | 154,206 | 165,416 | 163,089 | 185,722 | |||
| Due to related parties | ✕ | ✕ | ✕ | ✕ | 577 | 1,618 | |||
| Other liabilities | 3,786 | 2,858 | 4,255 | 4,961 | 7,063 | 6,440 | |||
| Operating lease, liability | 62,511 | 66,537 | 70,035 | 73,813 | 76,885 | 79,593 | |||
| Other undisclosed noncurrent liabilities | 69,662 | 69,072 | 66,051 | 65,187 | 64,028 | 66,113 | |||
| Total noncurrent liabilities: | 355,290 | 368,060 | 366,213 | 381,362 | 312,683 | 338,005 | |||
| Total liabilities: | 552,023 | 585,728 | 575,628 | 575,434 | 567,429 | 611,567 | |||
| Temporary equity, carrying amount | 21,480 | 21,480 | 21,480 | 21,480 | |||||
| Equity | |||||||||
| Equity, attributable to parent | (228,122) | (204,166) | (157,169) | (102,274) | (48,852) | (21,447) | |||
| Common stock | 995 | 988 | 983 | 982 | 966 | 942 | |||
| Additional paid in capital | 1,652,243 | 1,643,641 | 1,634,459 | 1,625,067 | 1,589,145 | 1,541,019 | |||
| Accumulated other comprehensive loss | (6,507) | (6,875) | (6,923) | (6,250) | (4,570) | (5,720) | |||
| Accumulated deficit | (1,874,853) | (1,841,920) | (1,785,688) | (1,722,073) | (1,634,393) | (1,557,688) | |||
| Equity, attributable to noncontrolling interest | 20,487 | 20,487 | 20,487 | 20,487 | 19,967 | 19,967 | |||
| Total equity: | (207,635) | (183,679) | (136,682) | (81,787) | (28,885) | (1,480) | |||
| TOTAL LIABILITIES AND EQUITY: | 365,868 | 423,529 | 460,426 | 515,127 | 538,544 | 610,087 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 55,902 | 27,138 | 40,134 | 44,319 | 36,161 | 34,367 | ||
| Cost of revenue | (25,753) | (5,407) | (4,243) | (5,708) | (3,491) | (4,925) | ||
| Gross profit: | 30,149 | 21,731 | 35,891 | 38,611 | 32,670 | 29,442 | ||
| Operating expenses | (61,212) | (75,926) | (99,373) | (126,659) | (108,761) | (95,594) | ||
| Operating loss: | (31,063) | (54,195) | (63,482) | (88,048) | (76,091) | (66,152) | ||
| Nonoperating income (expense) | 2,570 | 2,496 | 4,296 | 2,652 | 1,036 | 924 | ||
| Interest and debt expense | (4,996) | (5,068) | (5,022) | (3,069) | (2,372) | (1,119) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations before equity method investments, income taxes: | (33,489) | (56,767) | (64,208) | (88,465) | (77,427) | (66,347) | ||
| Income from equity method investments | 589 | 615 | 677 | 550 | 796 | 280 | ||
| Other undisclosed loss from continuing operations before income taxes | (2,638) | (1,573) | ||||||
| Loss from continuing operations before income taxes: | (32,900) | (58,790) | (63,531) | (87,915) | (76,631) | (67,640) | ||
| Income tax expense (benefit) | (33) | (80) | (84) | 235 | (74) | (108) | ||
| Loss from continuing operations: | (32,933) | (58,870) | (63,615) | (87,680) | (76,705) | (67,748) | ||
| Other undisclosed net income | 2,638 | 1,573 | ||||||
| Net loss available to common stockholders, diluted: | (32,933) | (56,232) | (63,615) | (87,680) | (76,705) | (66,175) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (32,933) | (56,232) | (63,615) | (87,680) | (76,705) | (66,175) | ||
| Other comprehensive income (loss) | 368 | 48 | (673) | (1,680) | 1,150 | 1,626 | ||
| Comprehensive loss, net of tax, attributable to parent: | (32,565) | (56,184) | (64,288) | (89,360) | (75,555) | (64,549) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.